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ABSTRACT
Ribosomal RNAs (rRNAs) act as scaffolds and ribozymes in
ribosomes, and these functions are modulated by post-transcriptional
modifications. However, the biological role of base methylation, a well-
conserved modification of rRNA, is poorly understood. Here, we
demonstrate that a nucleolar factor, nucleomethylin (NML; also known
as RRP8), is required for the N1-methyladenosine (m1A) modification
in 28S rRNAs of human and mouse cells. NML also contributes to 60S
ribosomal subunit formation. Intriguingly, NMLdepletion increases 60S
ribosomal protein L11 (RPL11) levels in the ribosome-free fraction and
protein levels of p53 through an RPL11–MDM2 complex, which
activates the p53 pathway. Consequently, the growth of NML-depleted
cells is suppressed in a p53-dependent manner. These observations
reveal a new biological function of rRNA base methylation, which links
ribosomal subunit formation to p53-dependent inhibition of cell
proliferation in mammalian cells.
KEY WORDS: Nucleolar factor, NML, rRNA modification, m1A, p53,
Cell proliferation
INTRODUCTION
Ribosomal RNAs (rRNAs) function as scaffolds for ribosomal
proteins and ribozymes for peptide bond formation (Nissen et al.,
2000; Steitz and Moore, 2003). Biosynthesis of rRNA comprises
transcriptional and post-transcriptional modification of precursor
(pre)-rRNAs as well as the processing of pre-rRNAs into mature
28S, 18S and 5.8S rRNAs (Henras et al., 2015). Nucleotide
modifications of rRNA regulate the function and stability of
ribosomes (Decatur and Fournier, 2002). There are three main types
of chemical modifications of rRNA – conversion of uridine to
pseudouridine (pseudouridylation); methylation of 2′-hydroxyls
(2′-O-ribose methylation); and alteration of bases, most of which
undergo methylation at different positions (base methylation)
(Decatur and Fournier, 2002). Of these modifications, base
methylations are the most conserved in terms of their total
number and position among living organisms, and are commonly
found at approximately ten positions in eukaryotic rRNAs
(Hauenschild et al., 2015; Sharma and Lafontaine, 2015). Base
methylation is considered to expand the structural repertoire of
RNA, facilitating base stacking by increasing hydrophobicity and
adjusting steric hindrance (Ishitani et al., 2008). To date, base
methylation of rRNA and the genes responsible for it (Bud23, Rrp8,
Nop2, Rcm1, Bmt2, Bmt5 and Bmt6) have been reported in
budding yeast (Gigova et al., 2014; Peifer et al., 2013; Sharma et al.,
2013; White et al., 2008). A very recent report has shown that yeast
and worm homologs of human NSUN5 methylate C2278 in 25S
rRNA of Saccharomyces cerevisiae and C2381 in 26S rRNA of
Caenorhabditis elegans; in addition, the reduction in the levels of
NSUN5 homologs decreases translational fidelity in yeast and
increases the lifespan of S. cerevisiae, C. elegans and Drosophila
melanogaster (Schosserer et al., 2015). The human ortholog of yeast
Bud23, WBSCR22 (Merm1), has also been shown to mediate
N7-methylation of G1639 and 18S rRNA maturation in cells (Haag
et al., 2015); however, little is known about the base
methyltransferase of rRNA in mammals.
In all organisms, ribosomes serve as the sole site of biologic
protein synthesis, and their biogenesis is strictly regulated. The
mammalian ribosome comprises two subunits composed of rRNAs
and ribosomal proteins (Anger et al., 2013; Khatter et al., 2015). The
small subunit (40S) is formed from a single molecule of rRNA (18S
rRNA) and 33 ribosomal proteins (ribosomal proteins of the small
ribosomal subunit; RPSs). Conversely, the large subunit (60S)
contains three rRNA molecules (5S, 5.8S and 28S) and 47 ribosomal
proteins (ribosomal proteins of the large subunit; RPLs).
Interestingly, ribosome biogenesis defects are coupled to inhibition
of cell proliferation that is mediated by p53 (encoded by TP53)
(Fumagalli et al., 2009; Sloan et al., 2013; Sulic et al., 2005). p53
functions as a tumor suppressor, and its activation induces apoptosis
and cell cycle arrest, resulting in cell growth suppression (Bieging
et al., 2014; Brooks and Gu, 2010; Vousden, 2000). Together with
these reports, recent studies suggest that quantitative and qualitative
changes in ribosomes are associated with numerous physiologic and
pathologic events (Barna et al., 2008; Belin et al., 2009, 2010;
Figueiredo et al., 2015; Marcel et al., 2013). However, it remains
unclear whether and how the base methylation of rRNA regulates
ribosomal functions and related biological events in mammals.
Nucleomethylin (NML; also known as RRP8) is a nucleolar
protein that binds to dimethyl lysine at position 9 of histone H3
(H3K9me2) in cells and suppresses ribosomal DNA (rDNA)
transcription in response to glucose deprivation (Grummt and
Ladurner, 2008; Murayama et al., 2008). NML contains the
Rossmann-fold methyltransferase-like domain in its C-terminal
half, and binds to S-adenosyl-L-methionine (SAM), although NML
does not exhibit methyltransferase activity toward histones
(Murayama et al., 2008). In contrast, the yeast NML homolog
Rrp8 has been identified as a gene responsible for the SAM-
dependent N1-methyladenosine (m1A) modification in the 25SReceived 19 November 2015; Accepted 29 April 2016
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rRNA (Peifer et al., 2013). However, the contribution of NML to
m1A modification has yet to be elucidated. In this study,
using mammalian cells, we reveal that NML is responsible for
m1A modification of 28S rRNA and contributes to the 60S
ribosomal subunit formation, and that NML deficiency inhibits cell
proliferation in a p53-dependent manner.
RESULTS
NML is required for m1A modification in 28S rRNA
In yeast 25S rRNA, two sites with the m1A modification have been
identified and, along with the neighboring sequences (Peifer et al.,
2013), these sites are well conserved among eukaryotes, including in
humans andmice (Fig. 1A; Fig. S1; A645 andA2142 of 25S rRNA in
Saccharomyces cerevisiae correspond to A1309 and A3625 of 28S
rRNA inHomo sapiens, and A1136 and A3301 of 28S rRNA inMus
musculus, respectively). To confirm the interaction between NML
and 28S rRNA in human epithelial adenocarcinoma HeLa cells, we
performed RNA immunoprecipitation (RIP) experiments using an
antibody against NML. In this assay, endogenousNML proteins were
precipitated using an antibody against NML. RNAs were then
purified from the precipitate, and 28S rRNA levels were quantified by
performing quantitative reverse-transcriptase (qRT)-PCR using a
specific primer set (Table S1). 28S rRNA was co-
immunoprecipitated with NML from the whole cell (Fig. 1B) and
nuclear extracts (Fig. 1C), indicating the association of NML with
28S rRNA. By contrast, 5S rRNA was not significantly co-
immunoprecipitated with NML (Fig. 1B,C). Next, to investigate the
effect of NML on rRNA methylation, we performed a method based
on site-specific semi-quantitative RT-PCR using HeLa cells in which
NML-knockdown (KD) constructs (shNML#1 and #2) were stably
expressed (Fig. 1D, left panel). Methylation levels around A1309,
which is methylated by Rrp8 in yeast, were significantly lower in
shNML-transfected cells than in control cells expressing shRNAs
against green fluorescent protein (shGFP) (Fig. 1D, right panel).
However, methylation levels around A3625, which is methylated by
Bmt2 in yeast (Sharma et al., 2013), were very low in control cells
[rRNA methylation levels around A1309 and A3625 (mean±s.d.)
were 19.05±0.47 and 1.32±0.21, respectively. These values were
calculated so that the value obtainedwith the qRT-PCR reaction at the
low dNTP concentration was normalized to that obtained at the high
dNTP concentration; see Materials and Methods.] and were not
markedly changed by knockdown of NML (Fig. S2A). Consistently,
methylation levels around A1136, which corresponds to A1309 of
28S rRNA in humans, were reduced in NML-knockout (NML KO)
immortalized mouse embryonic fibroblasts (MEFs), compared with
in NML wild-type (NML WT) MEFs (Fig. 1E; Fig. S2B). Primer
extension analysis was also performed to confirm the modification at
A1309 of HeLa cells and A1136 of immortalized MEFs in 28S
rRNAs. Strong stop signals at positions A1309 and A1136 were
observed in 28S rRNAs of shGFP and NMLWT cells (Fig. 1F). By
contrast, these stop signals were reduced using 28S rRNAs of NML
KD and KO cells. Moreover, the reduction of methylation levels
around A1136 was attenuated by the expression of FLAG- and
hemagglutinin (HA) FLAG–HA-tagged NML, but not by the
expression of control EGFP (Fig. 1G; Fig. S2C). These results
indicate that NML is involved in the modifications at A1309 and
A1136 in 28S rRNA of human and mouse cells.
To investigate whether NML regulates m1A modification of
28S rRNA, we then analyzed the base modifications of RNAs
that included a 28S rRNA fragment by performing liquid-
chromatography-coupled mass spectrometry (LC-MS/MS). In NML
KO and KD cells, the peaks corresponding to m1Amodification were
reduced compared with those in NML WT and control KD cells
(Fig. 2A,B). Moreover, RIP experiments using an antibody against
m1A revealed that m1A modifications around A1136 and A1309
were significantly reduced by NML depletion (Fig. 2C,D). These
results indicate that NML is responsible for m1A modifications at
positions 1309 and 1136 in human and mouse 28S rRNA.
A previous study has revealed that the C-terminal region of NML
contains a Rossman-fold methyltransferase-like domain, which
interacts with the methyl donor SAM (Murayama et al., 2008)
(Fig. 3A). To investigate whether this domain is indispensable for
rRNA methylation, we performed a site-specific semi-quantitative
RT-PCR-based method using the immortalized MEFs that stably
expressed FLAG–HA-tagged wild-type NML (NML-wt) or
mutated NML constructs (NML-mt1 or NML-mt2) that lack the
ability to bind to SAM (Murayama et al., 2008) (Fig. 3A,B).
Expression of NML-wt increased rRNA methylation levels around
A1136 in NML KO cells (Fig. 3C). Conversely, no significant
enhancement of rRNA methylation was induced by expression of
control EGFP, NML-mt1 or NML-mt2 in NML KO cells. These
results suggest that NML regulates m1A modification in 28S rRNA
through its methyltransferase-like domain.
NML contributes to the formation of the 60S ribosomal
subunit
Modifications of rRNA contribute to ribosomal subunit formation
and association (Decatur and Fournier, 2002; Polikanovet al., 2015).
To investigate the effect of knockdown of NML on the interaction
between ribosomal subunits, we used bimolecular fluorescence
complementation (BiFC) to visualize ribosomal subunit joining (Al-
Jubran et al., 2013). The 40S ribosomal protein S18 (RPS18) and
60S ribosomal protein L11 (RPL11), which are adjacent to each
other on the surface of each subunit, were tagged with the N- and C-
terminal halves of the yellow fluorescent protein Venus, respectively
(yielding S18-VN and L11-VC; Fig. 4A). Subunit interaction was
detected as Venus signal (hereafter referred to as BiFC signal; see
Materials andMethods).We validated this assay using fluorescence-
activated cell sorting (FACS) and confirmed that the BiFC signal
was only detected when S18-VN and L11-VC were co-transfected
(Fig. 4B). Moreover, the BiFC signal was dramatically reduced
when cells were treated with puromycin, an aminoacyl-tRNA-like
molecule that causes 80S dissociation (Al-Jubran et al., 2013; Blobel
and Sabatini, 1971) (Fig. 4B–D). These results suggest that the BiFC
signal derived from S18-VN and L11-VC expression is a
consequence of subunit interaction. Knockdown of NML
increased the population of cells that emitted a low BiFC signal
and decreased the proportion of cells that emitted a high BiFC signal
(Fig. 4C). The median BiFC signals were also decreased by
knockdown of NML (Fig. 4D). We then performed sucrose density
gradient centrifugation in the presence of EDTA, which dissociates
the 80S complex into the 40S and 60S subunits (Peifer et al., 2013);
the cell lysates were centrifuged and fractionated, and the ribosomal
subunit ratio was quantified by measuring the 18S and 28S rRNA
levels in each fraction (Fig. 5A). The ratio of 18S rRNA:28S rRNA
(amount of 18S rRNA divided by the amount of 28S rRNA) in
shNML cells was significantly higher than that of shGFP cells
(Fig. 5B). Notably, in these cell lines, 18S and 28S rRNAs were
distributed to similar extents in fractions 4–8 and 9–15, respectively
(Fig. 5A). Considering that this assay separates cellular organelles,
including ribosomal subunits, depending on their individual
densities (mass/volume), these results indicate that knockdown of
NML results in fewer 60S subunits, rather than the formation of
abnormal subunits.
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Next, we tested whether NML depletion alters bulk protein
translation by incorporating 35S-labeled methionine (35S-Met) into
proteins. Pretreatment with protein synthesis inhibitor cycloheximide
(CHX) fully blocked amino acid incorporation into newly synthesized
proteins (Fig. 5C). InNMLKDcells, the rates of 35S-Met incorporation
were not markedly different from those in control cells. Overall, these
results suggest that NML is involved in the formation of 60S ribosomal
subunits without affecting bulk protein synthesis.
Fig. 1. NML is required for modification in 28S rRNA. (A) Multiple sequence alignment of the regions neighboring two positions of N1-methyladenosine (m1A;
A645 and A2142 in squares) of 25S rRNA (613–663 and 2128–2160) in Saccharomyces cerevisiae, of 28S rRNA (1295–1327 and 3611–3643) inHomo sapiens
and of 28S rRNA (1122–1154 and 3287–3319) inMus musculus. Conserved nucleotides are marked with asterisks. (B,C) Interaction between rRNA and NML in
whole-cell extracts (B) and nuclear extracts (C) of HeLa cells. The binding of NML to 28S or 5S rRNAs was validated with RIP using an antibody against NML
(αNML). An unconjugated affinity purified immunoglobulin (IgG) from mouse was used as a control. In the left panel in C, protein levels of NML in the indicated
fractions were determined using western blot. α-tubulin and histone H3 (H3) were also used as cytoplasmic and nuclear markers, respectively. (D) Methylation
levels at a region of 28S rRNA, including A1309, in HeLa cells expressing shRNAs targeting GFP (shGFP) or NML shNML#1 or shNML#2 were analyzed by
performing qRT-PCR (right panel). shGFP was used as a control shRNA. Protein levels of NML in the indicated cells were determined using western blot (left
panel). (E) Methylation levels were analyzed by performing qRT-PCR (right panel) at a region of 28S rRNA, including A1136, in NML wild-type (WT) or knockout
(KO) immortalized MEFs. Protein levels of NML in the indicated cells were determined using western blot (left panel). (F) Modification state at A1309 of human
28S rRNA in shGFP- or shNML#2-expressing HeLa cells and at A1136 of mouse 28S rRNA in NMLWT or KO immortalized MEFs, analyzed by using primer
extension tests. (G) Expression of FLAG and HA (FLAG–HA)-tagged NML recovered the methylation levels around A1136 of 28S rRNA in NMLWT or KO
immortalized MEFs, demonstrated using western blot (left panel) and qRT-PCR (right panel). All values are presented as mean±s.d. of three independent
experiments. **P<0.01; ***P<0.005; n.s., not significant (bootstrap and permutation tests) in B–E,G).
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Previous reports have shown that NML inhibits rDNA
transcription in human cells under glucose deprivation, but not
under conditions with 1 g/l glucose (Murayama et al., 2008; Yang
et al., 2013) (Fig. S2D). Moreover, it has been reported that the
depletion of certain factors involved in ribosome biogenesis inhibits
rDNA transcription and/or pre-rRNA processing (Bousquet-
Antonelli et al., 2000). We investigated the effect of knockdown
of NML on rDNA transcription and processing under conditions
with 4.5 g/l glucose used in this study. In shNML-expressing HeLa
cells, mature and pre-rRNA levels were unchanged in comparison
with those in control cells (Fig. S2D). Furthermore, analysis of pre-
rRNA processing using metabolic labeling with 32P-orthophosphate
showed that there was no substantial change in the distribution
patterns on gels of pre-rRNA (47S and 45S, and 32S) and mature
rRNA (28S and 18S) between shNML- and shGFP-expressing
HeLa cells (Fig. S2E). These results indicate that NML affects
rRNA base methylation without altering rDNA transcription and
pre-rRNA processing under normal glucose conditions.
NML depletion induces activation of the p53 pathway
through RPL11
Location of ribosomal proteins outside of the ribosome increases
when ribosomal biogenesis is perturbed by nucleolar stress (Miliani
de Marval and Zhang, 2011; Zhang and Lu, 2009). Several
Fig. 2. NML is involved in m1A modification in 28S rRNA. (A,B) The amount of 28S rRNA m1A modified in NMLWT or KO immortalized MEFs (A) and
shGFP or shNML#2 HeLa cells (B) was analyzed by performing LC-MS/MS. (C,D) m1A levels around A1136 in 28S rRNA of NMLWT or KO immortalized MEFs
(C) and around A1309 in 28S rRNA of shGFP- or shNML-expressing HeLa cells (D) analyzed by RIP using an antibody against m1A (αm1A). An unconjugated
affinity purified IgG from mouse was used as a control. Values are presented as mean±s.d. of three independent experiments. ***P<0.005; n.s., not significant
(Student’s t-test) in C. **P<0.01; ***P<0.005; n.s., not significant (one-way ANOVA followed by Tukey’s test) in D.
Fig. 3. NML regulates 28S rRNAmethylation through its Rossman-foldmethyltransferase-like domain. (A) Schematic representation of wild-type (wt) NML
and point mutants in the Rossman-fold methyltransferase-like domain (mt1 and mt2). Conserved motifs in the SAM-methyltransferase are shown in red bars.
(B) Protein levels of NML inNMLWTor KO immortalized MEFs expressing EGFP as a control. Expression of wild-type or mutated (mt1 or mt2) FLAG–HA-tagged
NML was analyzed using western blot. (C) Methylation levels around A1136 of 28S rRNA in NML-KO immortalized MEFs, demonstrated by qRT-PCR analysis.
Values are presented as mean±s.d. of three independent experiments. ***P<0.005; n.s., not significant (bootstrap and permutation tests).
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ribosomal proteins, including RPL11, bind to MDM2 and inhibit
the E3 ubiquitin ligase function of MDM2 toward p53, leading to
p53 stabilization and activation (Deisenroth and Zhang, 2010;
Lohrum et al., 2003; Zhang et al., 2003). To investigate whether
NML is involved in p53 activation through ribosomal proteins
(Fig. 6A), we analyzed the levels of RPL11 protein in the ribosome-
free fraction by performing sucrose density gradient centrifugation
in the absence of EDTA. The amount of ribosome-free RPL11 was
increased in shNML cells (Fig. 6B; Fig. S3A), indicating elevated
RPL11 accumulation outside of the ribosome. Moreover, co-
immunoprecipitation experiments showed that the interaction
between RPL11 and MDM2 was increased in shNML cells
(Fig. 6C). p53 activity in the immortalized MEFs and HeLa cells
is inhibited by SV40 large T-antigen and by E6 protein from
oncogenic HPV type 16, respectively (Hoppe-Seyler and Butz,
1993; Kierstead and Tevethia, 1993). Thus, we used human colon
carcinoma HCT116 tp53 wild-type ( p53+/+) and null ( p53−/−)
cells, and investigated the possibility that NML depletion induces
p53 activation through RPL11. In p53+/+ cells, knockdown of NML
increased p53 protein levels, and this p53 accumulation was
abrogated by knockdown of RPL11 (Fig. 6D). The expression of
p53 target genes was induced by knockdown of NML in p53+/+
cells, but not in p53−/− cells, at both the mRNA and protein level
(Fig. 7). The activation of p53 target genes induced by NML
depletion was also observed in normal MEFs, but not in the
immortalized MEFs (Fig. S3B). Taken together, these results
indicate that NML knockdown increases the RPL11–MDM2
interaction and induces p53 activation.
NML regulates cell proliferation in a p53-dependent manner
p53 contributes to the regulation of cell proliferation by inducing
apoptosis and cell cycle arrest, or by inhibiting protein synthesis
(Bieging et al., 2014; Brooks and Gu, 2010; Tilleray et al., 2006;
Vousden, 2000). We investigated the effect of NML on these p53-
dependent cellular events. A terminal deoxynucleotidyl transferase
dUTP nick-end labeling (TUNEL) assay showed that the percentage
of TUNEL-positive cells was significantly increased by NML
knockdown in p53+/+ cells, whereas this was not the case in p53−/−
cells (Fig. 8A; Fig. S4A). Moreover, cell cycle analysis revealed that
NML knockdown decreased the proportion of S-phase cells and
increased the proportion of G2- andM- (G2/M) phase cells in a p53-
dependent manner 3 days after transfection with small interfering
(si)RNAs (Fig. 8B; Fig. S4B). The rates of 35S-Met incorporation
into synthesized proteins were reduced by NML knockdown in
p53+/+ cells (Fig. 8C). By contrast, in p53−/− cells, the rates of
incorporation of the labeled amino acid were not significantly
Fig. 4. The effect of knockdown of NML on the interaction between ribosomal subunits. (A) Crystal structure of the human ribosome (Protein DataBank ID,
4V6X; Khatter et al., 2015). RPS18 and RPL11 and A1309 are highlighted in different colors. The BiFC model of the ribosome is also schematically represented.
In this model, RPS18 and RPL11 are tagged with the N- and C-terminal parts of Venus, respectively (S18-VN and L11-VC). (B–D) The interaction between
ribosomal subunits in HeLa cells expressing shRNA targeting luciferase (shLuc) or NML (shNML#1 or #2) was analyzed by using BiFC following FACS analysis.
shLuc was used as a control shRNA. S18-VN and/or L11-VC were co-expressed in cells with mCherry as a transfection control marker, and treated with or without
puromycin (puro). Venus and mCherry emissions (BiFC signals) for shLuc-expressing HeLa cells in the conditions indicated are plotted in B. The distribution and
median of the BiFC signals are shown in C and D, respectively. Values are presented as mean±s.d. of three independent experiments. ***P<0.005 (one-way
analysis of variance followed by Tukey’s test).
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changed by NML knockdown. Consistent with these results, cell
proliferation was suppressed by NML knockdown in a p53-
dependent manner (Fig. 8D). NML knockdown also significantly
reduced methylation levels around A1309, as well as interactions
between ribosomal subunits in both p53+/+ and p53−/− cells
(Fig. 8E,F). Overall, our findings suggest that NML is involved in
large ribosomal subunit formation throughm1Amodification of 28S
rRNA, thereby regulating cell proliferation through the p53 pathway.
DISCUSSION
We showed that the nucleolar protein NML regulates m1A
modification of 28S rRNA in a SAM-binding-domain-dependent
manner (Figs 1–3). Additionally, NML depletion decreases 60S
subunit formation (Fig. 5A,B). Intriguingly, we observed that NML
depletion enhances RPL11–MDM2 interactions and increases levels
of p53 protein, thereby activating the p53 pathway (Figs 6 and 7).
Consequently, the proliferation of NML-depleted cells is suppressed
by p53-dependent apoptosis, cell cycle arrest and protein synthesis
inhibition (Fig. 8A–D). Therefore, our results suggest that NML is
involved in them1Amodification of 28S rRNA and that a deficiency
in NML inhibits cell proliferation in a p53-dependent manner.
NML was first identified as an H3K9me2-binding protein that
forms a complex with SIRT1 and SUV39H1 to suppress rDNA
transcription under glucose starvation (Murayama et al., 2008). Our
data raise the question of how the molecular function of
NML switches from an epigenetic suppressor to a base
methyltransferase. Interestingly, it has been recently reported that
NML binds directly to rRNA under normal glucose conditions
(Yang et al., 2013). Conversely, glucose deprivation inhibits the
interaction between NML and rRNA, thereby enhancing the
recruitment of SIRT1 to NML. Indeed, we confirmed that, at a
glucose concentration of 4.5 g/l, NML interacts with 28S rRNA in
HeLa cells (Fig. 1B,C) and that NML depletion does not change the
level of rDNA transcription (Fig. S2D). These results suggest that
NML functions as a methyltransferase for rRNA under normal
glucose conditions, whereas it functions as a suppressor of rDNA
transcription under glucose deprivation. Thus, NMLmightmodulate
distinct steps of ribosome biogenesis, involving rDNA transcription
and rRNA methylation, in response to environmental changes.
Of the rRNA modifications, 2′-O-ribose methylation, which
affects not only ribosome biogenesis but also ribosomal functions,
including translational efficiency and fidelity (Decatur and Fournier,
2002), is one of the best characterized. Furthermore, fibrillarin (FBL)
has been identified as a 2′-O-ribose methyltransferase (Decatur and
Fournier, 2003; Lin et al., 2011). Recently, it has been reported that
p53 directly represses FBL transcription and decreases the 2′-O-
ribose methylation of rRNAs, impairing the translational function of
ribosomes (Marcel et al., 2013). Furthermore, FBL overexpression
facilitates tumorigenesis and is associated with poor survival of
cancer-affected individuals, implying that rRNA modification plays
a crucial role in cancer development. Indeed, levels of m1A-modified
nucleosides are elevated in the urine of individuals with cancer (Itoh
et al., 1992, 1988). Our results suggest that the NML-dependentm1A
modification of rRNA could influence cancer development through
the p53 pathway. Therefore, potential roles of NML-dependent
modifications of rRNA in cancer development should be explored.
Fig. 5. NML is involved in the
formation of 60S ribosomal subunit.
(A,B) Ribosomal subunit formation in
shGFP-, or shNML#1- or shNML#2-
expressing HeLa cells were analyzed by
performing sucrose density gradient
centrifugation following qRT-PCR. 18S
and 28S rRNA levels in each fraction were
normalized against those in an input (A).
The ratios between the total amounts of
18S and 28S rRNAs are shown as subunit
ratios for the cells indicated (B). (C) The
total protein synthesis rate in the cells
indicated was measured based on
35S-methionine incorporation (incorp.)
into newly synthesized proteins.
Cycloheximide (CHX) was used as a
positive control. All values are presented
as mean±s.d. of three independent
experiments. *P<0.05; ***P<0.005; n.s.,
not significant (one-way ANOVA followed
by Tukey’s test) in B. ***P<0.005; n.s., not
significant (bootstrap and permutation
tests) in C.
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MATERIALS AND METHODS
Cell culture
HeLa cells were provided by the RIKEN Catalysis Research Center through
the National Bio-Resource Project of the Ministry of Education, Culture,
Sports, Science and Technology, Japan. Dr Akiko Murayama (University of
Tsukuba, Tsukuba, Japan) gifted SV40 large-T-antigen-immortalized NML
WT and KOMEFs, which were generated from C57BL/6J background wild-
type and NML-KO mice (Oie et al., 2014), respectively. HCT116 p53+/+ and
p53−/− cells were kindly provided by Dr Bert Vogelstein (John Hopkins
University, Baltimore, MD) (Bunz et al., 1998). All animal experiments were
approved and performed in accordancewith the guidelines for the care and use
of laboratory animals at University of Tsukuba. ForMEF isolation, embryos at
13.5 days post coitum from C57BL/6J mice (CLEA Japan, Tokyo, Japan)
were used. After the removal of the head and visceral tissues, the remaining
bodieswerewashed and dissociated.Cellswere plated ondishes and incubated
37°C with 5% CO2. The next day, floating cells were removed by washing in
PBS.MEFswere usedwithin three passages. Cells andMEFsweremaintained
in Dulbecco’s modified Eagle’s medium (DMEM; Gibco™, Thermo Fisher
Scientific) supplemented with 10% fetal bovine serum (FBS; Gibco™,
Thermo Fisher Scientific) and penicillin–streptomycin (Sigma-Aldrich).
Antibodies
Antibodies against the following proteins and epitopes were used in this
study: β-actin (Sigma-Aldrich; A5316; 1:5000); α-tubulin (Sigma-Aldrich;
T5168; 1:5000); Histone H3 (Cell Signaling Technology; 9715; 1:3000);
1-methyladenosine (m1A; MBL International, Nagoya, Japan; D345-3);
RPL11 (Cell Signaling Technology; 14382; 1:2000); MDM2 (Santa Cruz
Biotechnology; sc-965; 1:500); p53 (DO-1; Santa Cruz Biotechnology; sc-
126; 1:2000); 14-3-3σ (1.N.6; Abcam; ab14123; 1:2000); Bax (Abcam;
ab7977; 1:1000); and an unconjugated affinity purified isotype control
immunoglobulin (IgG) from mouse (Santa Cruz Biotechnology; sc-2025).
Previously reported anti-human and mouse NML antibodies were generated
(1:1000) (Murayama et al., 2008; Oie et al., 2014).
RNA interference
To generate stable knockdown cell lines, cells were transfected with the
piGENE™ hU6 plasmid (iGENE Therapeutics, Tsukuba, Japan) containing
sequences targeting NML, GFP or luciferase (Luc). The transfected cells
were selected with puromycin. The target sequences were: 5′-GCCGCTT-
TGAGGATGTTCGAA-3′ for shNML#1; 5′-GGGTAGTACTACAAAT-
GATCC-3′ for shNML#2 (Murayama et al., 2008); 5′-GGCTACGTCCA-
GGAGCGCACC-3′ for shGFP; and 5′-GTGCGCTGCTGGTGCCAACC-
C-3′ for shLuc.
For transient knockdown, cells were transfected with 20 nM of Stealth
RNAi™ short interfering RNA (siRNA) (Invitrogen) using Lipofectamine®
RNAiMAX (Invitrogen) according to the manufacturer’s protocol. The
target sequences were as follows: 5′-CCGCUUUGAGGAUGUUCGAA-
CCUUU-3′ for siNML#1 (human); 5′-CCUCAUACAUUAAGCCGCA-
AGCAGU-3′ for siNML#2 (human); 5′-CCAAACUCGGCUUUAAGA-
UUAUCUA-3′ for siNML (mouse); 5′-ACACAUCGAUCUGGGUAUC-
AAAUAU-3′ for siRPL11. Stealth RNAi™ Luciferase Reporter control
(siLuc) was used as a negative control.
Plasmid construction and mutagenesis
A plasmid containing mouse wild-type NML was constructed by inserting
the HindIII–NotI (blunt ended with Klenow)-digested fragment from
FLAG- and HA-tagged mouse NML in pcDNA3 (a gift from DrMurayama,
University of Tsukuba, Tsukuba, Japan) into the XhoI (filled with Klenow)
site of the plasmid pPB-CAG.EBNXN (kindly provided by Dr Allan
Bradley, Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, UK).
Mutations were introduced by using site-directed mutagenesis and PCR.
The primer sequences were as follows (altered sequences are underlined):
Fig. 6. NML depletion increases p53 protein levels through RPL11. (A) Schematic model of NML-dependent p53 accumulation through RPL11. In functional
NML cells, p53 is degraded byMDM2 (left pathway). Depletion of NML increases ribosome-free RPL11, which enhances the interaction of RPL11 with MDM2 and
induces p53 accumulation (right pathway). (B) Protein levels of RPL11 in the ribosome-free (free) or ribosomal (Ribo.) fraction of shGFP- or shNML#2-expressing
HeLa cells were analyzed by performing sucrose gradient centrifugation followed by western blotting (top three rows). 18S and 28S rRNAs are shown as
references for ribosome sedimentation (bottom row). (C) Interaction between RPL11 and MDM2 in shGFP- or shNML#2-expressing HeLa cells was analyzed
using immunoprecipitation (I.P.) with an antibody against MDM2 and western blotting. An unconjugated affinity purified IgG frommouse was used as a control for
immunoprecipitation. (D) Protein levels of p53 in HCT116 p53+/+ cells that had been treated with siRNA targeting luciferase (siLuc) orNML (siNML#1 or siNML#2)
and/or RPL11 (siRPL11). Two days after siRNA transfection, the levels of the indicated proteins were analyzed using western blot. Representative western blot
data are shown on the left. Graphs are expressed as the fold change relative to the indicated protein levels in siLuc-transfected HCT116 p53+/+ cells. Values are
presented as mean±s.d. of three independent experiments. **P<0.01; ***P<0.005; n.s., not significant (bootstrap and permutation tests).
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mouse NML mt1 (G317D,G319R), 5′-GCTGACTTTGACTGTAGAGA-
TTGCCGC-3′; mouse NML mt2 (G317Q), 5′-GCTGACTTTGGCTGTG-
AAGATTGCCGC-3′.
Western blotting
To detect proteins using western blotting, cells were lysed with RIPA
buffer [20 mMTris-HCl (pH 7.5), 150 mMNaCl, 2 mMEDTA, 0.8%Nonidet
P-40 (NP-40), 0.1% sodium dodecyl sulfate (SDS) and 0.5% sodium
deoxycholate]. Cell extracts were fractionated by performing SDS-PAGE and
transferred to a polyvinylidene difluoride membrane using transfer apparatus
according to the manufacturer’s protocol (Bio-Rad Laboratories). The
antibodies used are described in the Antibodies section. Quantitative analyses
of western blot data were performed using Multi Gauge version 3.0 software
(Fujifilm). Each protein level was normalized to the protein levels of β-actin.
Co-immunoprecipitation
Cells were lysed in RIPA buffer supplemented with EDTA-free protease
inhibitor cocktail (Nacalai Tesque, Kyoto, Japan). Equal amounts of
extracted proteins were resuspended in TNE buffer [10 mM Tris-HCl (pH
7.5), 150 mM NaCl, 1 mM EDTA, 1% NP-40] supplemented with EDTA-
free protease inhibitor cocktail, and were immunoprecipitated with the
indicated antibodies (1.8 μg/ml) and Dynabeads conjugated to protein G
(Invitrogen). Bound proteins were then analyzed by using western blot.
qRT-PCR
To quantify rRNA methylation levels, we performed a site-specific rRNA
methylation assay based on quantitative reverse-transcription (qRT)-PCR
(Belin et al., 2009; Marcel et al., 2013). Total RNAwas extracted and purified
using Sepasol-RNA I Super G (Nacalai Tesque) according to the
manufacturer’s instructions. Aliquots of total RNA (500 ng) were reverse
transcribed using ReverTra Ace® (Toyobo, Osaka, Japan) and 1 µM of each
reverse primer targeting a sequence downstream to a specific methylation site,
with either a low (2.5 µM) or high (250 µM) deoxy nucleoside triphosphate
(dNTP) concentration, according to the manufacturer’s instructions. qRT-
PCR was performed with SYBR® Premix Ex Taq™ II (Takara Bio, Otsu,
Japan) using a Thermal Cycler Dice™ Real-Time System (Takara Bio). The
amount of methylation was calculated following the function 2(CTlow−CThigh),
where the CT (threshold cycle) value obtained with the qRT-PCR reaction at
the low dNTP concentrationwas normalized to that obtained at the high dNTP
concentration. We used the following primer sets: hA1309_RT and
hA1309_Fw/Rv; hA3625_RT and hA3625_Fw/Rv; mA1136_RT and
mA1136_Fw/Rv; and mA3301_RT and mA3301_Fw/Rv (Table S1).
To quantify rRNA or mRNA levels, aliquots of total RNA (500 ng) were
reverse transcribed with a pd(N)6 random primer and 250 µM of dNTPs.
qRT-PCR was performed with primers for the indicated rRNA or genes
(Table S1). The expression level of each gene in human and mouse cells was
normalized to the mRNA levels of genes encoding human β-actin (ACTB)
and mouse cyclophilin (Ppia), respectively.
RNA immunoprecipitation
RIP was performed as previously described (Lin et al., 2011) with minor
modifications. For RIP against NML using nuclear lysates, cells were
harvested and resuspended in 450 μl buffer A [10 mM HEPES (pH 7.5),
10 mM KCl, 0.1 mM EDTA] (Dignam et al., 1983) and kept on ice for
Fig. 7. NML depletion activates the p53 pathway. (A) mRNA levels of p53 target genes in HCT116 p53+/+ or p53−/− cells that had been treated with siLuc or
siNML#1 or siNML#2. Three days after siRNA transfection, the levels of the indicated mRNAwere analyzed by performing qRT-PCR. Graphs are expressed as
the fold change relative to corresponding mRNA levels in siLuc-transfected HCT116 p53+/+ or p53−/− cells. (B) Protein levels of p53 targets in HCT116 p53+/+ or
p53−/− cells that had been treated with siLuc or siNML#1. Three days after siRNA transfection, the indicated protein levels were analyzed using western blot.
Representative western blot data are shown in the upper panel. Graphs show the fold change relative to the indicated protein levels in siLuc-transfected HCT116
p53+/+ cells (lower panel). All values are presented as mean±s.d. of three independent experiments. *P<0.05; **P<0.01; ***P<0.005; n.s., not significant
(bootstrap and permutation tests).
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15 min. Fifty microliters of 5% NP-40 in buffer A were added. Nuclei were
pelleted by centrifugation at 800 g for 5 min. Then, whole cells or nuclei
were suspended in 200 μl cold lysis buffer [10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (pH 7.5), 300 mM KCl, 5 mM MgCl2, 0.5%
NP-40, 1 mM dithiothreitol, EDTA-free protease inhibitor cocktail (Nacalai
Tesque) and 100 U/ml RNase Inhibitor (Toyobo]. Whole-cell or nuclear
extracts were centrifuged at 15,000 g for 15 min at 4°C, and the supernatant
was pre-cleared using protein-G–Sepharose® beads (GE Healthcare) and
treated with DNase I (Wako Pure Chemical Industries, Osaka, Japan) (60 U/
100 μl lysate) for 30 min on ice. The samples (2‒10 μg) were incubated with
Fig. 8. NML regulates cell proliferation in a p53-dependent manner. (A) Apoptosis assay of HCT116 p53+/+ or p53−/− cells that had been treated with siLuc, or
siNML#1 or siNML#2. Three days after siRNA transfection, the cells indicated were analyzed using TUNEL staining. For each group, cells were counted in three
randomly selected fields (more than 100 cells/field) per experiment. (B) Cell cycle analysis of HCT116 p53+/+ or p53−/− cells that had been treated with siLuc, or
siNML#1 or siNML#2. Three days after siRNA transfection, the indicated cells were analyzed using EdU staining following FACS analysis (left panel). The
percentages of the cell population in the S-phase were compared between the indicated cells (right panel). (C) The total protein synthesis rates in the cells
indicated were measured based on 35S-methionine incorporation (incorp.) into newly synthesized proteins 3 days after siRNA transfection. (D) Phase-contrast
images and growth curve of HCT116 p53+/+ or p53−/− cells that had been treated with siLuc, or siNML#1 or siNML#2. The phase-contrast images (left panel) were
taken three days after siRNA transfection. Scale bar: 100 µm. Living cells were counted at the times indicated after siRNA transfection using Trypan Blue staining
(right panel). The statistical significance between siLuc- and siNML#1- or siNML#2-expressing cells is shown by * and †, respectively. (E) Methylation levels at the
region of 28S rRNA that includes A1309 in HCT116 p53+/+ or p53−/− cells that had been treated with the indicated siRNAs. Three days after siRNA transfection,
methylation levels were analyzed by performing qRT-PCR. (F) Themedian BiFC signals in HCT116 p53+/+ or p53−/− cells that had been treated with the indicated
siRNAs. Three days after siRNA transfection, BiFC signals were analyzed by performing FACS. All values are presented as mean±s.d. of three independent
experiments in A–C,E,F and of three wells in D from a representative experiment that was performed at least three times with similar results. * or †P<0.05;
**P<0.01; *** or †††P<0.005; n.s., not significant (one-way ANOVA followed by Tukey’s test) in A,B,D,F. **P<0.01; ***P<0.005; n.s., not significant (bootstrap and
permutation tests) in C,E.
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pre-binding antibodies (5 μg) and protein-G–Sepharose® beads in 1000 μl
NT2 buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM MgCl2 and
0.05% NP-40] including 100 U of RNase inhibitor, 10 mM dithiothreitol
and 20 mM EDTA overnight at 4°C. The beads were washed twice with
NT2 buffer and resuspended in 100 μl of NT2 buffer. The suspension was
mixed with 100 μl of proteinase K buffer [30 μg proteinase K, 20 mM Tris-
HCl (pH 7.8), 10 mM EDTA and 1.0% SDS] and incubated for 30 min at
55°C. After centrifugation, RNAs were purified from the supernatant using
phenol–chloroform–isoamyl-alcohol and analyzed by performing qRT-
PCR. Whole-cell or nuclear extracts were used as input samples for
normalization of qRT-PCR data.
For RIP against m1A, total RNAs were extracted using Sepazol-RNA I
Super G and treated with DNase I. Purified RNAs were fragmented using an
NEBNext® Magnesium RNA Fragmentation Module (New England
Biolabs). Fragmented RNAs were precipitated with ethanol after adding
20 μg of glycogen and resuspended in 100 µl of IPP buffer [10 mM Tris-
HCl (pH 7.5), 150 mM NaCl and 0.1% NP-40]. RNA samples were added
to 100 µl of an antibody mixture that included IPP buffer and 50 μl of
protein-G–Sepharose® beads. The mixture was rotated overnight at 4°C.
The beads were washed twice with IPP buffer. Immunoprecipitated RNAs
were purified by phenol–chloroform–isoamyl-alcohol extraction, and
analyzed using qRT-PCR. Total RNAs were used as input samples for
normalization of qRT-PCR data.
Primer extension
Primer extension was performed as per previously described protocols
(Cozen et al., 2015; Sharma et al., 2013) with minor modifications. One
micromole of DNA primer was 32P-5′-terminally labeled by incubation in a
final volume of 25 μl with 15 μCi γ-[32P]ATP and 9 U of polynucleotide
kinase in protruding kinase buffer (Toyobo). The reaction was incubated at
37°C for 1 h. The reaction mixture was then purified using Illustra™
MicroSpin™ G-25 columns (GE Healthcare). For the extension reaction,
0.5 μl of the 32P-5′-phosphorylated primer was annealed by heating for
3 min at 95°C, followed by cooling on ice using 0.2 μg total RNA in 4.75 μl
RT buffer (Toyobo) containing 2.5 μM dNTPs. Annealed primers were
extended using 0.25 μl ReverTra Ace® (25 U) for 1 h at 42°C, stopped by
the addition of 5 μl formamide loading dye and frozen at −80°C. Primer
extension products were resolved by performing electrophoresis on 8%
polyacrylamide gels containing 4 M urea. Gels were dried and exposed to
Amersham Hyperfilm™ ECL (GE Healthcare). DNA primer sequences
(hA1309_RT and mA1136_RT) used for primer extension are listed in
Table S1.
Quantification of methylated ribonucleosides with LC-MS/MS
28S rRNA was isolated from total RNA by performing agarose gel
electrophoresis and using the NucleoSpin® Gel and PCR Clean-up system
(Macherey-Nagel, Düren, Germany) according to the instruction manual.
After denaturation by heating at 100°C for 3 min, 1–2 µg of 28S rRNAwas
immediately chilled on ice. Denatured RNA was hydrolyzed by 1 U of
nuclease P1 (Wako Pure Chemical Industries) in 10 mM ammonium acetate
buffer (pH 5.3) at 45°C for 2 h, subsequently dephosphorylated by
incubating with phosphodiesterase I (0.0002 U, Sigma-Aldrich), alkaline
phosphatase (0.3 U, Toyobo) and 0.1 volume of 1 M ammonium
bicarbonate buffer (pH 7.9) at 37°C for 2 h, as described previously
(Crain, 1990). Ten pmol of br5U (Tokyo Chemical Industry, Tokyo, Japan)
were added into the digestion mixture as an internal standard; the enzymes
were subsequently removed by acetone precipitation. The supernatant was
left to evaporate, and the ribonucleoside powder was dissolved with 15 µl of
HPLC-grade water (Wako Pure Chemical Industries).
Individual ribonucleosides were quantified using a Shimadzu Nexera™
UHPLC system coupled to LCMS-8050™ triple quadrupole mass
spectrometer (Shimadzu, Kyoto, Japan). Reverse-phase HPLC separation
was carried out using a Kinetex™ 2.6 µm C18 column (2.1×150 mm,
Phenomenex, Torrance, CA, USA) with a VANGUARD™ Pre-Column
(2.1×5 mm, Waters Co., Milford, MA, USA) at 30°C with 80% acetonitrile
in 0.1% formic acid (solvent B) gradient in 0.1% formic acid (solvent A) at a
flow rate of 0.2 ml/min. The abovementioned water-dissolved sample (5 µl)
was injected and eluted with the following gradient elution: initial isocratic
elution with 0% solvent B for 3 min, followed by linear gradient elution
from 0 to 8% B until 19 min, jumping to 100% B within 2 min and holding
the status until 25.5 min. The column was then subsequently returned to the
initial conditions within 1 min and equilibrated for 4.5 min before the next
sample injection. For determining elution positions of ribonucleosides on
the chromatogram, standard chemicals of m1A (Santa Cruz Biotechnology),
N6-methyladenosine (m6A) (Carbosynth, Compton, Berkshire, UK) and
br5U were used, and their retention times were revealed as 2.23 min,
15.1 min and 11.58 min, respectively.
The mass spectrometer was operated with an ion-spray source at 300°C in
positive ion mode, with unit resolution for Q1 and Q3, and other optimized
parameters: interface voltage, 4.0 kV; interface current, 0.1 µA; flow rate of
nebulizer gas, 3 l/min; flow rate of heating gas, 10 l/min; flow rate of drying
gas, 10 l/min; collision gas (Ar), 270 kPa; desolvation line temperature,
250°C; heat block temperature, 400°C; conversion dynode potential, 10 kV;
detector potential, 2.44 kV. Multiple reaction monitoring was used for
detection of nucleosides with a dwell time of up to 100 ms. Q1 was set to
transmit the parental ions MH+ atm/z 282.1, 282.1 and 324.6 for m1A, m6A
and br5U, respectively. The daughter ions were monitored in Q3 at m/z
150.1, 150.1 and 193.05 for m1A, m6A and br5U, respectively. Linear
calibration curves were obtained daily.
All of the solvents and reagents used in this analysis were HPLC grade.
Instrument control and data processing were performed using the
LabSolutions LCMS (Ver.5.60) software (Shimadzu Co.).
Bimolecular fluorescence complementation
The BiFC assay was performed as described previously (Al-Jubran et al.,
2013). To generate plasmids expressing BiFC-tagged ribosomal proteins,
the sequences of RPS18 and RPL11were PCR-amplified from the cDNA of
HeLa cells using primers tagged with SacI and XbaI or ApaI and KpnI,
respectively. RPS18 and RPL11 segments were cloned into pBiFC-VN173
(Addgene, 22010) and pBiFC-VC155 (Addgene, 22011), respectively
(Shyu et al., 2008). Using Lipofectamine® LTX (Invitrogen), these BiFC
plasmids were co-transfected with a pmCherry-N1 plasmid (Clontech
Laboratories), which was used as an internal control. Twenty-four hours
after transfection, cells were further cultured with or without 100 µg/ml
puromycin for 24 h. The cells were washed twice with STM buffer
[phosphate-buffered saline (PBS) with 2% FBS] and resuspended in 500 μl
of STM buffer. The fluorescence intensities of Venus and mCherry were
measured by flow cytometry using a BD FACSAria™ II (BD Biosciences).
The BiFC signal emitted by a cell was calculated using the following
function: (fluorescent intensity of Venus)/(fluorescent intensity of
mCherry), as previously described (Hu et al., 2002).
rRNA processing
Cells were cultured with methionine-free medium for 1 h, and then with
methionine-free medium containing 20 µCi/ml 32P-labeled inorganic
phosphate for 1 h (Sloan et al., 2013). The metabolic labeling media were
removed, and the cells were cultured with normal medium for 3 h. RNAwas
extracted using a FastPure™RNAKit (Takara Bio) and analyzed by glyoxal
agarose gel electrophoresis. Total RNA was visualized using ethidium
bromide staining. The intensity of each band was analyzed with the Multi
Gauge version 3.0 (Fujifilm).
Sucrose density gradient centrifugation
Sucrose density gradient centrifugation was performed as described
previously (Peifer et al., 2013; Tuorto et al., 2012).
To investigate ribosomal subunit formation, cells were treated with
100 µg/ml cycloheximide (CHX) in culture medium for 5 min at 37°C. The
cells were washed twice with PBS containing CHX (100 µg/ml) and lysed
with lysis buffer [15 mMTris-HCl (pH 7.5), 300 mMNaCl, 25 mMEDTA,
1% Triton X-100, 0.5 mg/ml heparin, 100 µg/ml CHX, 1× EDTA-free
protease inhibitor cocktail (Nacalai Tesque) and 100 U/ml RNase inhibitor
(Toyobo)]. The lysate was centrifuged at 9300 g for 10 min at 4°C and
loaded onto a linear 20–50% sucrose gradient buffer in 15 mM Tris-HCl
(pH 8.0), 25 mM EDTA and 300 mM NaCl. Centrifugation was conducted
at 40,000 rpm for 2 h at 4°C in a SW-41 Ti rotor (Beckman Coulter), and
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fractions were collected from the top of the gradient (#1 to #19). The 18S
and 28S rRNA levels in the fractions #1 to #18 were quantified by
performing qRT-PCR and normalized against those rRNA levels in an input
control. The ratio of 18S rRNA:28S rRNA (18S rRNA divided by 28S
rRNA) was calculated as the small:large ribosomal subunit ratio.
To obtain the ribosomal or ribosome-free fractions, we performed sucrose
density gradient centrifugation using lysis and gradient buffers containing
15 mM MgCl2 instead of 25 mM EDTA. 18S and 28S rRNAs, and β-actin
proteins were used as indicators for the ribosomal and ribosome-free
fractions, respectively (Lee et al., 2013; Morello et al., 2011).
Analysis of protein synthesis using 35S-methionine incorporation
This experiment was performed as previously described (Itani et al.,
2003; Mieulet et al., 2007). Cells were plated onto 12-well plates in
complete medium and transfected with or without siRNAs. One day after
cell seeding or 3 days after transfection, the culture medium was switched
to methionine-free DMEM with or without 50 μg/ml CHX for 30 min
at 37°C, and cells were incubated with the same medium containing
20 μCi/ml 35S-methionine (PerkinElmer) for 2 h at 37°C. Cells were then
washed twice with ice-cold PBS and solubilized in 50 µl of RIPA buffer
containing protease inhibitors. Aliquots of the supernatant were analyzed
using a liquid scintillation counter (Beckman Coulter) and normalized
against the total protein content.
5-ethynyl-2′-deoxyuridine staining for cell cycle analysis
For 5-ethynyl-2′-deoxyuridine (EdU) staining, cells were plated (1×105
cells/well in a 6-well plate) and cultured for the indicated number of days
after siRNA transfection. Then, this experiment was conducted using a
Click-iT® EdU Imaging Kit (Invitrogen), according to the manufacturer’s
protocol. First, cells were labeled with 10 µM EdU (Invitrogen) in culture
medium for 1 h at 37°C. For subsequent DNA staining, EdU-stained cells
were incubated with 2 µg/ml Hoechst 33342 (Sigma-Aldrich) for 10 min.
Then the cells were washed with PBS and subjected to FACS by using flow
cytometry in a BD FACSAria™ II instrument (BD Biosciences).
Terminal deoxynucleotidyl transferase dUTP nick-end labeling
assay
Cells were plated onto poly-D-lysine-coated (BD Biosciences) 8-well
chamber slides (1.6×104–2.4×104 cells/well) and cultured for 1, 2, 3 or
4 days after siRNA transfection. Then, the cells were fixed with 4%
paraformaldehyde in PBS for 25 min at 4°C, and in situ detection of
apoptotic cells was performed using DeadEnd™ Fluorometric TUNEL
System (Promega), according to the manufacturer’s instructions. Nuclei
were then counterstained using 2 µg/ml Hoechst 33342. The cells were
examined using the fluorescent microscope imaging system Biorevo BZ-
9000 (Keyence, Osaka, Japan), and TUNEL-positive cells were quantified
in three fields per sample. The percentage of TUNEL-positive cells was
calculated as follows: (TUNEL-positive/total cells)×100.
Cell proliferation assay
We seeded 1×105 cells/well in 6-well plates and transfected them with the
indicated siRNA. The cells were then trypsinized into single-cell
suspensions and automatically counted using a TC10™ Automated Cell
Counter (Bio-Rad Laboratories) on days 1, 2, 3 and 4, where the first day
after seeding was day 0.
Statistics
The unpaired Student’s t-test was used to compare two groups, and one-way
ANOVA followed by Tukey’s post-hoc test was used to compare multiple
groups. The statistical analysis of fold-change data was performed by
bootstrap and permutation tests using the web application BootstRatio
(Cler̀ies et al., 2012).
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